Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
Ainos (NASDAQ:AIMD), a pioneer in AI-powered scent digitization, has announced its participation in an upcoming fireside chat with Water Tower Research (WTR) scheduled for April 8, 2025, at 10:00 a.m. ET.
The discussion will feature WTR's senior research analyst Do Kim and managing director John Roy. During the session, Ainos will explore various aspects of their AI Nose technology, including:
- Applications in smart manufacturing and robotics
- Impact of AI-driven digitized smell beyond healthcare
- Recent collaboration programs in robotic and semiconductor manufacturing
- Technological advancements in training AI's digital olfaction
- Market opportunities across different industries
The event will be listen-only, with a replay available on Ainos' investor relations website.
Ainos (NASDAQ:AIMD), un pioniere nella digitalizzazione degli odori alimentata dall'IA, ha annunciato la sua partecipazione a un prossimo fireside chat con Water Tower Research (WTR) programmato per 8 aprile 2025, alle 10:00 ET.
La discussione vedrà la partecipazione dell'analista senior di WTR, Do Kim, e del direttore generale John Roy. Durante la sessione, Ainos esplorerà vari aspetti della loro tecnologia AI Nose, tra cui:
- Applicazioni nella manifattura intelligente e nella robotica
- Impatto dell'odore digitalizzato guidato dall'IA oltre il settore sanitario
- Recenti programmi di collaborazione nella produzione robotica e nei semiconduttori
- Progressi tecnologici nell'addestramento dell'olfatto digitale dell'IA
- Opportunità di mercato in diversi settori
L'evento sarà ascoltabile solo, con una registrazione disponibile sul sito web delle relazioni con gli investitori di Ainos.
Ainos (NASDAQ:AIMD), un pionero en la digitalización de olores impulsada por IA, ha anunciado su participación en un próximo fireside chat con Water Tower Research (WTR) programado para 8 de abril de 2025, a las 10:00 a.m. ET.
La discusión contará con la participación del analista senior de WTR, Do Kim, y del director general John Roy. Durante la sesión, Ainos explorará varios aspectos de su tecnología AI Nose, incluyendo:
- Aplicaciones en fabricación inteligente y robótica
- Impacto del olor digitalizado impulsado por IA más allá de la atención médica
- Programas de colaboración recientes en fabricación robótica y de semiconductores
- Avances tecnológicos en el entrenamiento del olfato digital de la IA
- Oportunidades de mercado en diversas industrias
El evento será solo para escuchar, con una repetición disponible en el sitio web de relaciones con inversores de Ainos.
Ainos (NASDAQ:AIMD)는 AI 기반 향기 디지털화의 선구자로서 Water Tower Research (WTR)와의 파이어사이드 채팅에 참여할 것이라고 발표했습니다. 이 행사는 2025년 4월 8일 오전 10시 ET로 예정되어 있습니다.
논의에는 WTR의 수석 연구 분석가인 Do Kim과 전무 이사 John Roy가 참여합니다. 세션 동안 Ainos는 AI Nose 기술의 다양한 측면을 탐구할 예정입니다:
- 스마트 제조 및 로봇 공학에서의 응용
- 의료 분야를 넘어선 AI 기반 디지털 냄새의 영향
- 로봇 및 반도체 제조에서의 최근 협력 프로그램
- AI의 디지털 후각 훈련에 대한 기술 발전
- 다양한 산업에서의 시장 기회
이 행사는 청취 전용으로 진행되며, Ainos의 투자자 관계 웹사이트에서 재생이 가능합니다.
Ainos (NASDAQ:AIMD), un pionnier dans la numérisation des odeurs alimentée par l'IA, a annoncé sa participation à un prochain fireside chat avec Water Tower Research (WTR) prévu pour le 8 avril 2025 à 10h00 ET.
La discussion mettra en vedette l'analyste senior de WTR, Do Kim, et le directeur général John Roy. Au cours de la session, Ainos explorera divers aspects de leur technologie AI Nose, y compris :
- Applications dans la fabrication intelligente et la robotique
- Impact de l'odeur numérisée par IA au-delà du secteur de la santé
- Programmes de collaboration récents dans la fabrication robotique et de semi-conducteurs
- Avancées technologiques dans la formation de l'olfaction numérique de l'IA
- Opportunités de marché dans différents secteurs
L'événement sera uniquement à l'écoute, avec une rediffusion disponible sur le site web des relations avec les investisseurs d'Ainos.
Ainos (NASDAQ:AIMD), ein Pionier in der KI-gestützten Duftdigitalisierung, hat seine Teilnahme an einem bevorstehenden Fireside Chat mit Water Tower Research (WTR) angekündigt, der für 8. April 2025, um 10:00 Uhr ET geplant ist.
Die Diskussion wird den leitenden Forschungsanalysten von WTR, Do Kim, und den Geschäftsführer John Roy umfassen. Während der Sitzung wird Ainos verschiedene Aspekte ihrer AI Nose-Technologie untersuchen, darunter:
- Anwendungen in der intelligenten Fertigung und Robotik
- Einfluss von KI-gesteuertem digitalem Geruch über den Gesundheitssektor hinaus
- Aktuelle Kooperationsprogramme in der Robotik- und Halbleiterfertigung
- Technologische Fortschritte in der Schulung des digitalen Geruchs von KI
- Marktmöglichkeiten in verschiedenen Branchen
Die Veranstaltung wird nur zum Zuhören sein, mit einer Wiederholung, die auf der Investor-Relations-Website von Ainos verfügbar ist.
- None.
- None.
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that it will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") and John Roy, managing director of WTR on Tuesday, April 8, 2025, at 10:00 a.m. ET.
Ainos will provide insights into AI Nose applications, including its use in smart manufacturing and robots, as well as the impact of AI-driven digitized smell on industries beyond healthcare. Ainos will also discuss its recent collaboration programs in the robotic and semiconductor manufacturing industries, along with technological and AI advancements in training AI's digital olfaction , and market opportunities across different industries.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" in the Ainos' investor relations website at https://ir.ainos.com/
About Ainos, Inc.
Ainos, Inc. (NASDAQ: AIMD) is an AI-driven healthcare and technology company pioneering scent digitization, AI-powered point-of-care testing, and novel therapeutics. Its AI Nose technology digitizes scent into Smell IDs, enabling applications in healthcare, robotics, and smart manufacturing. Ainos also develops VELDONA®, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. The name "Ainos" combines "AI" and "Nose", reflecting its mission to digitize smell, enhance AI capabilities, transform industries, with the ultimate vision of becoming AI's nose. For more information, visit: www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information
Feifei Shen
ir@ainos.com
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Ainos (AIMD) hosting the Water Tower Research fireside chat?
What topics will be covered in the AIMD fireside chat with Water Tower Research?
How can investors access the AIMD Water Tower Research fireside chat?
What industries is AIMD targeting with its AI-powered scent digitization technology?
